Accelerated Enrollment Solutions (AES) helps biopharmaceutical companies overcome patient recruitment and research site challenges to deliver greater speed, certainty, and control to clinical trial delivery.
Through the combination of a powerful patient recruiting solution and more than 160 owned and partnered clinical research sites throughout the world, AES provides a single global source for clinical trial sites and patients that delivers centralized control, consistent operations and quality worldwide, and more patients from fewer sites in less time.
AES is a business of PPD, a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services.
For more information, visit www.globalAES.com.
The Real Cost of Complexity: What Every Drug Developer Needs to Know December 16, 2024 12:01pm
Increased clinical trial complexity has significantly contributed to rising costs. Learn what's driving both and how to respond successfully.
The post The Real Cost of Complexity: What Every Drug Developer Needs to Know appeared first on PPD.
View this post
Overcoming Issues of Non-Enrolling Sites in Clinical Trials: A Proactive Approach November 25, 2024 11:18am
Here's how we utilize innovative approaches and data-driven insights to proactively tackle the challenges of non-enrolling sites.
The post Overcoming Issues of Non-Enrolling Sites in Clinical Trials: A Proactive Approach appeared first on PPD.
View this post
Leveraging FSP Solutions and Expertise to Keep Up With Regulatory Intelligence Systems Monitoring November 18, 2024 11:42am
FSP solutions are often optimal to ensure comprehensive and cost-effective pharmacovigilance regulatory intelligence.
The post Leveraging FSP Solutions and Expertise to Keep Up With Regulatory Intelligence Systems Monitoring appeared first on PPD.
View this post
Redefining Acceleration of the Drug Development Journey November 11, 2024 2:18pm
Accelerator Drug Development, Thermo Fisher Scientific’s 360˚ CDMO and CRO solutions, enables customers to get treatments to patients faster.
The post Redefining Acceleration of the Drug Development Journey appeared first on PPD.
View this post
Global Survey Highlights Drug Development Challenges and Opportunities November 4, 2024 1:38pm
A survey of biotech and biopharma leaders highlights key barriers and opportunities they share in accelerating drug development.
The post Global Survey Highlights Drug Development Challenges and Opportunities appeared first on PPD.
View this post
Key Trends Drug Developers Need to Know to Succeed October 31, 2024 4:27pm
We surveyed 150 drug developers around the globe to assess drug development trends and opportunities in 2024. Here’s what we found.
The post Key Trends Drug Developers Need to Know to Succeed appeared first on PPD.
View this post
